UWM
VKTX icon

Urban Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Urban Wealth Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$15K Buy
+5,291
New +$13.1K 0.05% 171

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Urban Wealth Management's VKTX Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Viking Therapeutics (VKTX) in Q2 2022: 5,291 shares worth $15K. The stake represents 0.05% of the portfolio and ranks #171 among its holdings.

114 funds tracked by Wall St. Rank hold VKTX as of Q2 2022.

  • Urban Wealth Management held 5,291 shares of Viking Therapeutics worth $15K as of Q2 2022.
  • Viking Therapeutics was a new Urban Wealth Management position in Q2 2022.
  • Viking Therapeutics made up 0.05% of Urban Wealth Management's portfolio in Q2 2022, its #171 holding.
  • 114 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.